Free shipping in Canada on orders over $75.A.Vogel Echinaforce® Extra:
- Can be taken by pregnant and breast feeding women
- Sugar- and gluten-free
- Echinacea purpurea is known for its antiviral, antibacterial and anti-inflammatory properties
- Organic cultivation certified by Bio Suisse
- Take at the first sign of infection.
- Efficacy clinically proven
Each Tablet Contains Dry Extract of:
Fresh organically grown* Echinacea (Echinacea purpurea) Herb (ratio 5.4:1)|17.67mg
equivalent to 95mg of organically grown* dried herb
Root (ratio 5.9:1)|0.93mg
equivalent to 5.5mg of organically grown* dried root
Made with 1200mg of fresh echinacea tincture per tablet.
*Certified by: Bio Suisse
Non-Medicinal Ingredients: Lactose , starch , vegetable magnesium stearate , soya polysaccharides.
Fresh organically grown* Echinacea (Echinacea purpurea) Herb (ratio 5.4:1)|17.67mg
equivalent to 95mg of organically grown* dried herb
Root (ratio 5.9:1)|0.93mg
equivalent to 5.5mg of organically grown* dried root
Made with 1200mg of fresh echinacea tincture per tablet.
*Certified by: Bio Suisse
Non-Medicinal Ingredients: Lactose , starch , vegetable magnesium stearate , soya polysaccharides.
Adult: 15 mins before meals;
Prevention: Take 1-2 tablets daily.
Acute Treatment: Take 3-4 tablets daily. Tablets can be swallowed or chewed.
Echinaforce® Extra are clinically proven safe to be taken by pregnant and nursing women.
Caution: Consult a healthcare practitioner prior to use if you are taking immunosuppressants, or if you have an autoimmune disorder or a progressive systemic disease such as: tuberculosis, collagenosis, AIDS and/or HIV infections or multiple sclerosis, . Discontinue immediately in case of hypersensitivity/allergic reaction. Do not use if you have an allergy to Asteraceae/Compositae (daisy) family and elderberries or in case of known allergy to any of the ingredients in the product. Consult a healthcare practitioner if symptoms persist or worsen.
Melchart, Dieter, et al. "Echinacea root extracts for the prevention of upper respiratory tract infections: a double-blind, placebo-controlled randomized trial."Archives of Family Medicine 7.6 (1997): 541-545
